Fremont, CA – According to filings with the U.S. Securities and Exchange Commission, Q’Apel Medical is raising $21,999,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, King Nelson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Q’Apel Medical

In the simplest sense, we’re a company that creates solutions. More specifically, we design novel access device technology for vascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in. With exceptional experience across the technical, clinical, manufacturing, and operations needs in the neurovascular space, we pride ourselves not merely on devising adaptations to technologies that exist but also looking beyond what’s been done to what might come next.

To learn more about Q’Apel Medical, visit http://qapelmedical.com/

Contact:
King Nelson, Chief Executive Officer
510-738-6255
https://www.linkedin.com/in/king-nelson-449b4812/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reservedz